Hemopexin: a review of biological aspects and the role in laboratory medicine.
about
Kinetics and specificity of feline leukemia virus subgroup C receptor (FLVCR) export function and its dependence on hemopexinHemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contendersSemi-quantitative measurement of a specific glycoform using a DNA-tagged antibody and lectin affinity chromatography for glyco-biomarker developmentRole of hemoglobin/heme scavenger protein hemopexin in atherosclerosis and inflammatory diseasesIdentification of reduced circulating haptoglobin concentration as a biomarker of the severity of pulmonary embolism: a nontargeted proteomic studySemi-automated identification of N-Glycopeptides by hydrophilic interaction chromatography, nano-reverse-phase LC-MS/MS, and glycan database searchHemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes.The concentrations of EGFR, LRG1, ITIH4, and F5 in serum correlate with the number of colonic adenomas in ApcPirc/+ ratsFeasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders.Plasma biomarkers in pediatric patients undergoing cardiopulmonary bypass.Iron-related proteins: candidate urine biomarkers in childhood HIV-associated renal diseasesThe obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2).Comparison and consolidation of microarray data sets of human tissue expression.Identification of serum biomarkers in dogs naturally infected with Babesia canis canis using a proteomic approach.Serum biomarkers which correlate with failure to respond to immunotherapy and tumor progression in a murine colorectal cancer model.A large, consistent plasma proteomics data set from prospectively collected breast cancer patient and healthy volunteer samples.Placental heme receptor LRP1 correlates with the heme exporter FLVCR1 and neonatal iron statusProteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers.Specific protein content of pools of plasma for fractionation from different sources: impact of frequency of donationsQuantification of fucosylated hemopexin and complement factor H in plasma of patients with liver diseaseAn alternative view of the proposed alternative activities of hemopexin.Haptoglobin polymorphism and body iron stores.Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice.Control of intracellular heme levels: heme transporters and heme oxygenasesIdentification of circulating biomarkers in sera of Plasmodium knowlesi-infected malaria patients--comparison against Plasmodium vivax infection.Alterations in the Atlantic cod (Gadus morhua) hepatic thiol-proteome after methylmercury exposure.The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.Red Blood Cells Preconditioned with Hemin Are Less Permissive to Plasmodium Invasion In Vivo and In VitroUrinary biomarkers of kidney diseases in HIV-infected children.Passively released heme from hemoglobin and myoglobin is a potential source of nutrient iron for Bordetella bronchiseptica.Proteomic screening of glycoproteins in human plasma for frailty biomarkersHbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics.Comparison of Integrated Responses to Nonlethal and Lethal Hypothermal Stress in Milkfish (Chanos chanos): A Proteomics Study.One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoansHemopexin as biomarkers for analyzing the biological responses associated with exposure to silica nanoparticles.Prolonged neutrophil dysfunction after Plasmodium falciparum malaria is related to hemolysis and heme oxygenase-1 inductionRenal cortical hemopexin accumulation in response to acute kidney injury.Nrf2 to pre-condition the brain against injury caused by products of hemolysis after ICH.Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension.Utilizing spectral counting to quantitatively characterize tandem removal of abundant proteins (TRAP) in human plasma
P2860
Q24338112-4FFA4B6C-CDAC-4D21-8C68-B28F941599C1Q26801681-1FC264E8-5C04-436A-8847-ADA9873744EBQ27311617-AB265C63-05CA-4656-807A-6CA48C55EC02Q28266961-3D62DC54-265A-4F76-959D-907938599801Q28540157-983EB78F-F938-4237-8479-4F9562BF712EQ28731567-C794B607-9C89-431D-B0DF-79F7152A7356Q30484244-05B0333E-A05A-488F-AC66-7FBCC5946BB9Q30596947-E0CA8F22-F3FD-4139-A4AA-8B3DCCC73E70Q30823738-BE10DFEE-AE04-4E6F-B8E3-7EFC389E9A3AQ33322284-DA93D5CC-AC76-4592-A6B5-6DBDD51609D6Q33383651-4CE4BD1A-BCE1-4845-BA2B-406AD74126CDQ33519162-6D1FBE96-A102-4FB4-B430-6BB136619305Q33577494-CFD193C8-5ADB-4B07-88EE-45DF63052FAEQ33712315-7ECB4F9F-95A1-487D-A946-C8AFC40DC505Q33764534-A6B1936E-32C4-4EDC-AD70-1EF29157B293Q33914424-C92A81C0-BD77-470A-9EB8-7BC26BEE313BQ34334896-2637AC8B-AE15-41F3-9854-6A8A3FAE2639Q34388636-87061109-BE06-4C55-B067-C83383BD3186Q34401639-A364C0E5-868A-4D9E-BFA1-E597C7559647Q34464343-70D2C32A-97A5-4107-91D6-BFD32D135979Q34627609-51B7AD31-DBB4-42D8-AC32-FAEC7B068216Q34634285-E8686D33-3F99-4D1C-93F1-BB7279AA904FQ34700468-AD662D9D-6FA0-4F31-AA57-2C4A73998CC3Q34810793-24804D81-6955-4C50-A14D-44095BBBFBABQ35108515-8FCF261D-37A0-41EE-8092-097969AFF937Q35154509-FAB31219-03D9-4A48-ADA5-FFDFBEACDFB9Q35774227-4CA2E814-468F-43A6-9A7A-10C36C6167F9Q35806409-B2762B5B-20A7-42E2-8C27-1E4FA60FB76CQ35934081-E77AC1BB-FF22-4AC3-BED4-DFA4F21AE8CFQ36097298-D7062521-C3D0-4240-B95C-CDA1D59A2747Q36112458-7EE2F84F-598B-4AD4-B30A-E8AFE54809D3Q36138738-6244B6FD-BF8C-4DEE-A414-319EE0BA17F0Q36141050-3EEC4A3B-2938-418D-A0A6-3B41417109EBQ36143730-465CAA6C-35DD-4ADB-ACE1-8B7446FBEA44Q36368022-8066CA8B-B5EF-4928-A1D4-27BF242F29EAQ36418387-1FCE636F-AA95-43F1-AF0E-1AD39A3E19F2Q36454161-4271EE81-9827-462E-9D46-DE3910CA9585Q36573668-3726C2A9-7D14-405D-9F45-EFD6938CC80AQ36601764-A3C62974-06B9-498D-9DCD-DCEC36370261Q36846090-D597F750-A140-4D3D-98F0-58223FA0356D
P2860
Hemopexin: a review of biological aspects and the role in laboratory medicine.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Hemopexin: a review of biological aspects and the role in laboratory medicine.
@ast
Hemopexin: a review of biological aspects and the role in laboratory medicine.
@en
Hemopexin: a review of biological aspects and the role in laboratory medicine.
@nl
type
label
Hemopexin: a review of biological aspects and the role in laboratory medicine.
@ast
Hemopexin: a review of biological aspects and the role in laboratory medicine.
@en
Hemopexin: a review of biological aspects and the role in laboratory medicine.
@nl
prefLabel
Hemopexin: a review of biological aspects and the role in laboratory medicine.
@ast
Hemopexin: a review of biological aspects and the role in laboratory medicine.
@en
Hemopexin: a review of biological aspects and the role in laboratory medicine.
@nl
P1433
P1476
Hemopexin: a review of biological aspects and the role in laboratory medicine.
@en
P2093
Delanghe JR
Langlois MR
P356
10.1016/S0009-8981(01)00586-1
P577
2001-10-01T00:00:00Z